Last Price$29.3(3.2%)
Market Cap$1,656.1M
31.0%
Industry median - 3.6%
5Y Historical average - 210.8%
35.4%
Industry median - 8.2%
5Y Historical average - 234.4%
(4.5%)
Industry median - (12.5%)
5Y Historical average - 66.6%
(15.7%)
Industry median - 10.8%
5Y Historical average - 162.0%
JANX Growth Rating
JANX Growth rating
5.7
JANX Growth rating performance
JANX Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with JANX Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$1,656.1M | 5.7 | N/A | 31.0% | (76.6%) | N/A | (4.5%) | 38.6% | N/A | (15.7%) | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the Janux Therapeutics, Inc. (JANX) revenue growth?
The Janux Therapeutics, Inc. (JANX) revenue growth is 31.0%, which is lower than the industry median of 3.6% and the 5-year historical average of 210.8%.
What is the Janux Therapeutics, Inc. (JANX) operating income growth?
The Janux Therapeutics, Inc. (JANX) operating income growth is 35.4%, compared to the industry median of 8.2% and the 5-year historical average of 234.4%.
What is the Janux Therapeutics, Inc. (JANX) EPS (Earnings Per Share) growth?
The Janux Therapeutics, Inc. (JANX) EPS growth is (4.5%), compared to the industry median of (12.5%) and the 5-year historical average of 66.6%.
What is the Janux Therapeutics, Inc. (JANX) Free Cash Flow (FCF) growth?
The Janux Therapeutics, Inc. (JANX) Free Cash Flow growth is (15.7%), compared to the industry median of 10.8% and the 5-year historical average of 162.0%.